BioMed X Launches New T Cell Immunology Discovery Platform
BioMed X unveiled its new immunology discovery platform designed to allow for the accurate and fast identification of target antigens of human T cell...
Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs
JSR Life Sciences, LLC, announced that Similis Bio, its business unit focused on biosimilar development, have formed a partnership with Novel351k to co-develop three...
Altasciences announced that it is expanding its laboratory facilities in Columbia, MO.
The expansion is on track to be completed this year. The new 8,000 square-foot space will mirror Altasciences’ current bioanalytical laboratory in Laval, Québec, with...
Receptor Location Significant For Psychedelic Drug Effect
For psychedelic medications to effectively cure mental disease by swiftly re-establishing connections between nerve cells, the location happens to be crucial. In a study...
Australia Moves Itself Towards The Biotech ESG Guidance
A group of committed AusBiotech leaders has joined forces to create an Australian biotech first: a sector-specific environmental, social, and governance (ESG) tool in...
Neoadjuvant Nivolumab Aids In Long Term Lung Cancer Survival
Final assessments of a Phase II trial for resectable non-small cell lung cancer found that 60% of patients who had gone on to receive...
CMS Tests Three New Ways To Bring Down The Cost of Drugs
It has come to light that the federal health agencies have gone on to select three new models so as to lower the prices...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...